CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $961K invested in Cellectar Biosciences in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$395K
2
+$179K
3
+$125K
4
Morgan Stanley
Morgan Stanley
New York
+$36.9K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$33.3K

Top Sellers

1
-$3K
2
-$2K
3
-$2K
4
TRCT
Tower Research Capital (TRC)
New York
-$2K
5
LTFS
Ladenburg Thalmann Financial Services
Florida
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$395K
2
$179K
3
$125K
4
$85K
5
$65K
6
$59K
7
$20K
8
$19K
9
$10K
10
$1K
11
$1K
12
$1K
13
$1K
14
–
15
–